CRISPR/Cas9 Engineered TIL for Enhanced Anti-Tumor Function
Time: 2:00 pm
day: Day 1 - Track B - Lunch
Details:
- CRISPRomics® screens for identification of target and target combinations to enhance T cell anti-tumor function
- Application of top targets for generation of eTILTM therapy
